0
Home
News
Directory
E-newsletter
Magazine
Events
Data
AgReport
Subscribe
Inocucor received U.S. patent for microbials
Nov. 20, 2015
Concentric Agriculture Inc. (formally called Inocucor)
United StatesFollow
United StatesInocucor Technologies Inc., the Montreal-based agriculture biotech company, was issued patent No. 9,175,258 by the U.S. Patent and Trademark Office to protect Inocucor consortia and unique microbial products.
Based in Montreal, ON, Inocucor produces sustainable bio-based products that improve crop yields, shorten growing periods and create healthier, more resilient soils for organic farmers, greenhouse growers and mainstream production farmers. Its core technology was developed in 2007 by Dr. Bywater–Ekegärd and Ananda Lynn Fitzsimmons, who believed that microbial, rather than chemical, solutions would be needed to help farmers feed a growing world population.
This initial patent relates to Inocucor’s live IN-M1 microbial consortium and its fermentation byproducts, which are the basis of the formulation for Inocucor Garden Solution, the company’s first-generation growth-accelerator product. Garden Solution is formulated to naturally sustain robust plant growth, increase plant vigor and actively build a friable and rich soil, improving the health of the entire phyto-microbiome.
The patent applies to each of the individual Inocul-M microorganisms characterized by Inocucor and in other task-specific live consortia like IN-M1. Also protected are the biological ingredients produced during Inocucor’s multi-species manufacturing process.
Source: Inocucor
More from AgroNews
Change
Hot TopicSubscribe
| Subscribe Email: | * | |
| Name: | ||
| Mobile Number: | ||
Comment
0/1200
NEWSLETTER